New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

CVS Health Corporation

CVS

Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.

Revenue
+5.37%
EPS
n/m
Free cash flow
+3,886.7%
Total debt
−7.83%

Quarter to September 2026, against a year earlier

80.05 1.30 −1.60%

After hours trading: 80.05, unchanged, last trade Thu 7:55pm Eastern.

Market cap
$102.4B
P/E
9.2×
Fwd P/E FY26e
12.8×
Dividend yield
3.32%
F-score
7/9
ROIC
7.44%
Net debt / EBITDA
3.6×
Payout ratio
0.3×

CVS Health Corporation (CVS) revenue by segment, product and region

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.